First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
PARIS, May 27 /PRNewswire/ --
- Collaborative groups set out to confirm potential benefits of anticancer therapies to treat women with breast cancer
A new international study for women with HER2-…